Christopher Ma, MD, of @ucalgary.bsky.social, discusses results from the RESOLVE trial, evaluating #EP104GI, an injectable formulation of the steroid fluticasone, for treatment of #EosinophilicEsophagitis. #GISky
📹 Watch the full interview with Dr Ma here:
www.docwirenews.com/post/injecta...
📹 Watch the full interview with Dr Ma here:
www.docwirenews.com/post/injecta...
Injectable Steroid for EoE | Docwire News
In the phase 1b/2 RESOLVE study, EP-104GI, an injectable formulation of the steroid fluticasone, showed promise in the treatment of eosinophilic esophagitis.
www.docwirenews.com
July 13, 2026 at 9:27 PM
Christopher Ma, MD, of @ucalgary.bsky.social, discusses results from the RESOLVE trial, evaluating #EP104GI, an injectable formulation of the steroid fluticasone, for treatment of #EosinophilicEsophagitis. #GISky
📹 Watch the full interview with Dr Ma here:
www.docwirenews.com/post/injecta...
📹 Watch the full interview with Dr Ma here:
www.docwirenews.com/post/injecta...